| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | yes | yes: 45 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 24 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 19 |
| NetGPI | no | yes: 0, no: 19 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0032991 | protein-containing complex | 1 | 11 |
| GO:1990904 | ribonucleoprotein complex | 2 | 11 |
| GO:0016020 | membrane | 2 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 4 |
| GO:0005634 | nucleus | 5 | 3 |
| GO:0005737 | cytoplasm | 2 | 2 |
| GO:0031974 | membrane-enclosed lumen | 2 | 1 |
| GO:0031981 | nuclear lumen | 5 | 1 |
| GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
| GO:0043226 | organelle | 2 | 3 |
| GO:0043227 | membrane-bounded organelle | 3 | 3 |
| GO:0043229 | intracellular organelle | 3 | 3 |
| GO:0043231 | intracellular membrane-bounded organelle | 4 | 3 |
| GO:0043233 | organelle lumen | 3 | 1 |
| GO:0070013 | intracellular organelle lumen | 4 | 1 |
| GO:0097014 | ciliary plasm | 5 | 1 |
| GO:0099568 | cytoplasmic region | 3 | 1 |
Related structures:
AlphaFold database: E9AXC7
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003676 | nucleic acid binding | 3 | 20 |
| GO:0003723 | RNA binding | 4 | 20 |
| GO:0005488 | binding | 1 | 20 |
| GO:0097159 | organic cyclic compound binding | 2 | 20 |
| GO:1901363 | heterocyclic compound binding | 2 | 20 |
| GO:0003729 | mRNA binding | 5 | 3 |
| GO:0003730 | mRNA 3'-UTR binding | 6 | 2 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_MEL_PAP_1 | 48 | 54 | PF00089 | 0.341 |
| CLV_PCSK_KEX2_1 | 98 | 100 | PF00082 | 0.324 |
| CLV_PCSK_PC1ET2_1 | 98 | 100 | PF00082 | 0.324 |
| CLV_PCSK_SKI1_1 | 46 | 50 | PF00082 | 0.324 |
| CLV_PCSK_SKI1_1 | 98 | 102 | PF00082 | 0.350 |
| DOC_CYCLIN_RxL_1 | 43 | 50 | PF00134 | 0.524 |
| DOC_MAPK_gen_1 | 98 | 104 | PF00069 | 0.524 |
| DOC_WW_Pin1_4 | 3 | 8 | PF00397 | 0.721 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.729 |
| LIG_FHA_2 | 36 | 42 | PF00498 | 0.524 |
| LIG_IBAR_NPY_1 | 142 | 144 | PF08397 | 0.605 |
| LIG_LIR_Nem_3 | 50 | 55 | PF02991 | 0.546 |
| LIG_LIR_Nem_3 | 69 | 75 | PF02991 | 0.647 |
| LIG_SH2_CRK | 72 | 76 | PF00017 | 0.581 |
| LIG_SH2_STAT3 | 115 | 118 | PF00017 | 0.625 |
| LIG_SH2_STAT3 | 156 | 159 | PF00017 | 0.693 |
| LIG_SH2_STAT5 | 35 | 38 | PF00017 | 0.550 |
| LIG_SH3_3 | 17 | 23 | PF00018 | 0.712 |
| MOD_CK1_1 | 79 | 85 | PF00069 | 0.524 |
| MOD_CK2_1 | 36 | 42 | PF00069 | 0.524 |
| MOD_GlcNHglycan | 106 | 109 | PF01048 | 0.689 |
| MOD_GlcNHglycan | 78 | 81 | PF01048 | 0.346 |
| MOD_NEK2_1 | 104 | 109 | PF00069 | 0.675 |
| MOD_PKA_2 | 63 | 69 | PF00069 | 0.524 |
| MOD_ProDKin_1 | 3 | 9 | PF00069 | 0.721 |
| TRG_ENDOCYTIC_2 | 72 | 75 | PF00928 | 0.582 |
| TRG_Pf-PMV_PEXEL_1 | 46 | 50 | PF00026 | 0.324 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A1X0P4G4 | Trypanosomatidae | 65% | 80% |
| A0A1X0P4M7 | Trypanosomatidae | 67% | 96% |
| A0A3Q8IBN4 | Leishmania donovani | 45% | 70% |
| A0A3Q8ID53 | Leishmania donovani | 97% | 100% |
| A0A3S7WYY4 | Leishmania donovani | 100% | 100% |
| A0A422NWY7 | Trypanosoma rangeli | 72% | 100% |
| A4HDZ1 | Leishmania braziliensis | 90% | 100% |
| A4HDZ2 | Leishmania braziliensis | 86% | 100% |
| A4HDZ4 | Leishmania braziliensis | 44% | 70% |
| A4I191 | Leishmania infantum | 97% | 100% |
| A4I193 | Leishmania infantum | 45% | 70% |
| E9AH94 | Leishmania infantum | 99% | 72% |
| E9AXC6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 100% | 100% |
| E9AXC9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 45% | 70% |
| Q4QA43 | Leishmania major | 47% | 70% |
| Q4QA45 | Leishmania major | 98% | 100% |
| Q4QA46 | Leishmania major | 99% | 100% |
| V5BNA6 | Trypanosoma cruzi | 70% | 100% |